Cantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $7.00 target price on the stock. A number of other equities research analysts have also recently issued reports on the stock. Piper Sandler began coverage on […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have covered the stock […]
Wealthcare Advisory Partners LLC Buys 2,350 Shares of Franklin U.S. Large Cap Multifactor Index ETF (BATS:FLQL) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “overweight” rating reissued by analysts at Cantor Fitzgerald in a research report issued on Thursday, Benzinga reports. They currently have a $7.00 price target on the stock. Cantor Fitzgerald’s price target would suggest a potential upside of 191.67% from the company’s current price. A […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s stock price was up 5.1% during trading on Thursday . The stock traded as high as $2.86 and last traded at $2.86. Approximately 47,066 shares traded hands during trading, a decline of 98% from the average daily volume of 2,712,542 shares. The stock had previously closed […]